These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7494844)

  • 1. [Exclusive chemotherapy in T1-T3N0 cancers of the vocal cord with complete clinical response after neoadjuvant treatment with a cisplatin-fluorouracil combination].
    Laccourreye O; Bassot V; Brasnu D; Jouffre V; Ménard M; Laccourreye H
    Presse Med; 1995 Oct; 24(29):1337-40. PubMed ID: 7494844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
    Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
    J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
    Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Limited" cancers of the glottic stage of the larynx and exclusive chemotherapy--15 years of experience].
    Laccourreye H
    Bull Acad Natl Med; 1997 Apr; 181(4):641-8; discussion 648-9. PubMed ID: 9312344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
    Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
    Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
    Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
    Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure.
    Laccourreye O; Veivers D; Bassot V; Ménard M; Brasnu D; Laccourreye H
    Ann Otol Rhinol Laryngol; 2002 Apr; 111(4):315-21; discussion 321-2. PubMed ID: 11991582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Larynx preservation: nonsurgical approaches].
    Bourhis J; Lefebvre JL; Temam S; Lusinchi A; Janot F; Wibault P; Pignon JP
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S24-8. PubMed ID: 15679243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer.
    Eisbruch A; Thornton AF; Urba S; Esclamado RM; Carroll WR; Bradford CR; Hazuka MB; Littles FJ; Strawderman M; Wolf GT
    J Clin Oncol; 1996 Aug; 14(8):2322-30. PubMed ID: 8708724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
    Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation.
    Wolf GT; Fisher SG
    Laryngoscope; 1992 Aug; 102(8):934-9. PubMed ID: 1495357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
    Céruse P; Cosmidis A; Belot A; Rabilloud M; Fuchsmann C; Poupart M; Ramade A; Tartas S; Favrel V; Pommier P; Zrounba P; Fayette J
    Anticancer Drugs; 2014 Sep; 25(8):970-5. PubMed ID: 24849707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
    Pointreau Y; Garaud P; Chapet S; Sire C; Tuchais C; Tortochaux J; Faivre S; Guerrif S; Alfonsi M; Calais G
    J Natl Cancer Inst; 2009 Apr; 101(7):498-506. PubMed ID: 19318632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol.
    de Andrés L; Brunet J; López-Pousa A; Burgués J; Quer M; León X; Guedea F; Vega M; Mesía R; López JJ
    Laryngoscope; 1995 Aug; 105(8 Pt 1):822-6. PubMed ID: 7630294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group.
    Spaulding MB; Fischer SG; Wolf GT
    J Clin Oncol; 1994 Aug; 12(8):1592-9. PubMed ID: 8040671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of chemotherapy in squamous cell tumors of the larynx].
    Merlano M; Benasso M; Cavallari M; Muttini MP
    Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():129-34. PubMed ID: 1718139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.